Article in Molecular pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 1 institution in 3 countries.
Omar HashimINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0001-6208-3452
Claude L CharvetINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0002-0596-6598
Berthine ToubatéINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0003-4880-1651
Aimun A E AhmedINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0002-6403-132X
Nicolas LamassiaudeINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0002-2470-9490
Cédric NeveuINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0003-4314-1850
Isabelle Dimier-PoissonINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0001-8917-4493
Françoise Debierre-GrockiegoINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.).ORCID 0000-0001-7050-3891
Catherine DupuyINRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.) catherine.dupuy@univ-tours.fr.ORCID 0000-0002-3947-3580
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Molecular and Functional Characterization of GABA Receptor Subunits GRD and LCCH3 from Human Louse · full record | OpenQuestion